Lasofoxifene and confusional state Patient Reports March 22, 2010

Lasofoxifene Side Effects Report #5776169-3
Lasofoxifene side effect was reported by a Consumer or non-health professional from CANADA on June 13, 2008. Female patient, 78 years of age, weighting 156.5 lb, was diagnosed with osteoporosis  and was treated with Lasofoxifene. After drug was administered, patient experienced the following side effects: confusional state. Lasofoxifene dosage: 0.5 MG; DAILY; ORAL. During the same period patient was treated with LORAZEPAM, OSCAL, ALENDRONATE, LEVOTHYROXINE, TRAZODONE, ACETAMINOPHEN, DOCUSATE, CLONIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.